Results 281 to 290 of about 75,785 (301)

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

Blood, 2012
James N Kochenderfer, Mark E Dudley, Steven A Feldman   +2 more
exaly  

B Lymphocyte Antigen CD19

2016
openaire   +1 more source

Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells

Blood, 2010
James N Kochenderfer, Zhiya Yu, Nicholas P Restifo   +2 more
exaly  

Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice

Molecular Therapy, 2018
Christopher A Pennell, Angela Panoskaltsis-Mortari, Michael Loschi   +2 more
exaly  

A New Frontier: CD19 Chimeric Antigen Receptor T-Cell Therapy

Pediatric Annals
Lolita, Alcocer Alkureishi, Joseph R, Hageman   +1 more
openaire   +2 more sources

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma

Annals of Oncology, 2018
Pier Luigi Zinzani, Gianluca Gaidano, Mariano Provencio   +2 more
exaly  

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line

International Journal of Molecular Sciences, 2020
Chung Hyo Kang, Hye-Gwang Jeong, Chi Hoon Park   +2 more
exaly  

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Molecular Therapy, 2017
Frederick L Locke, Sattva S Neelapu, Nancy L Bartlett   +2 more
exaly  

CD19 regulates B lymphocyte responses to transmembrane signals

Seminars in Immunology, 1998
Manabu Fujimoto, Jonathan C Poe, Thomas Tedder   +2 more
exaly  

CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer

Cancer Immunology, Immunotherapy, 2018
Qi Jiang, Qiang Fu, Yu Zhu
exaly